Suvretta Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,562,852	Closed	-$18.8M	–	102
2024 Q1	$18.8M	Buy	+2,562,852	New	+$18.8M	0.7%	39
2020 Q3	–	Sell	-75,000	Closed	-$2.57M	–	102
2020 Q2	$2.57M	Buy	+75,000	New	+$2.57M	0.06%	67